Dilated Cardiomyopathy Evaluation with Imagenomics: Combining Multimodal Cardiovascular Imaging and Genetics
Authors:
- Kristian GalantiKGKristian Galanti
- Ghaith Sharaf DabbaghGDGhaith Sharaf Dabbagh
- Fabrizio RicciFabrizio Ricci
- Sabina GallinaSGSabina Gallina
- Roberta GiansanteRGRoberta Giansante
- Ron JacobRJRon Jacob
- Edmond Obeng-GyimahEOEdmond Obeng-Gyimah
- Leslie T. CooperLCLeslie T. Cooper
- Sanjay K. PrasadSPSanjay K. Prasad
- David H. BirnieDBDavid H. Birnie
- Andrew P. LandstromALAndrew P. Landstrom
- Selma F. MohammedSMSelma F. Mohammed
Open Access
- 24 April 2025
- journal article
- review article
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 12 (4) , 2669-2690
Abstract
Dilated cardiomyopathy (DCM) is a clinical diagnosis characterized by the presence of left ventricular dilatation and systolic dysfunction unexplained by abnormal loading conditions or coronary artery disease. However, a broad range of phenotypic manifestations, encompassing isolated scar, DCM with preserved ejection fraction, and overt DCM, should be regarded as a diagnostic classification representing a broad spectrum of underlying aetiologies, including both inherited and acquired heart muscle disorders. A multimodal non-invasive imaging approach is essential for accurate morpho-functional assessment of cardiac chambers and is key to establish the cardiac phenotype and to rule out an underlying ischaemic aetiology. Furthermore, advanced imaging techniques enable deep cardiovascular phenotyping and non-invasive tissue characterization. The aim of this review is to propose a systematic approach to the diagnosis of DCM, emphasizing the importance of genetics and clinical findings for a precise and practical clinical approach. Also, we strive to qualify the role of cardiac imaging in the diagnosis of DCM, particularly on the relevance of novel techniques and clinical utility of actionable parameters to improve current diagnostic schemes and risk stratification algorithms. We further elaborate on the role of cardiac imaging to deliver optimal guidance to aetiology-based therapeutic approaches, verification of treatment response and disease progression monitoring.Keywords
Funding Information
- European Union (ECS00000041)
- European Commission (ECS00000041)
This publication has 129 references indexed in Scilit:
- Early-Onset Atrial Fibrillation and the Prevalence of Rare Variants in Cardiomyopathy and Arrhythmia GenesJAMA Cardiology, 2021
- Risk of Nephrogenic Systemic Fibrosis in Patients With Stage 4 or 5 Chronic Kidney Disease Receiving a Group II Gadolinium-Based Contrast AgentJAMA Internal Medicine, 2020
- Evolving Concepts in Dilated CardiomyopathyEuropean Journal of Heart Failure, 2017
- Long-Term Prognostic Impact of Therapeutic Strategies in Patients with Idiopathic Dilated Cardiomyopathy: Changing Mortality over the Last 30 YearsEuropean Journal of Heart Failure, 2013
- Association of Fibrosis With Mortality and Sudden Cardiac Death in Patients With Nonischemic Dilated CardiomyopathyJAMA, 2013
- Assessment of real‐time myocardial uptake and enzymatic conversion of hyperpolarized [1‐13C]pyruvate in pigs using slice selective magnetic resonance spectroscopyContrast Media & Molecular Imaging, 2012
- Clinical contributions of 64-slice computed tomography in the evaluation of cardiomyopathy of unknown originArchives of Cardiovascular Diseases, 2009
- Incidence, Causes, and Outcomes of Dilated Cardiomyopathy in ChildrenJAMA, 2006
- Genetics of Idiopathic Dilated CardiomyopathyHerz, 2000
- Inferring microstructural features and the physiological state of tissues from diffusion‐weighted imagesNMR in Biomedicine, 1995